Overview
Evidence-based recommendations on the My5‑FU assay for measuring levels of 5‑flurouracil (5‑FU) in patients having chemotherapy, to help guide changes to the dose of 5‑FU.
Last reviewed: 20 February 2018
We reviewed the evidence and found nothing new that affects the recommendations in this guidance. See the review decision for more details.
Diagnostics guidance 16 has been migrated to HealthTech guidance 360. The recommendations and accompanying content remain unchanged.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.